Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101929953 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TGM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MANEAL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRCC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNT16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRP15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EIF3M - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NANP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHBDD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARFGAP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RMDN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCFD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPDL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on